Page last updated: 2024-11-05

triazolam and Narcosis

triazolam has been researched along with Narcosis in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Narcosis: A state of depressed CENTRAL NERVOUS SYSTEM marked by stupor or insensibility.

Research Excerpts

ExcerptRelevanceReference
"Stupor is a diagnostic challenge at emergency department."1.48Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor. ( Antelmi, E; Busardò, FP; Moresco, M; Pichini, S; Pizza, F; Plazzi, G; Postiglione, E, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Postiglione, E1
Antelmi, E1
Moresco, M1
Pichini, S1
Pizza, F1
Plazzi, G1
Busardò, FP1

Other Studies

1 other study available for triazolam and Narcosis

ArticleYear
Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018, 04-15, Volume: 14, Issue:4

    Topics: Adult; Hair; Humans; Male; Recurrence; Stupor; Substance-Related Disorders; Time Factors; Triazolam

2018